DOVITINIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where DOVITINIB was used for Lung neoplasm malignant.
Most Reported Side Effects for DOVITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 7 | 18.4% | 0 | 3 |
| Deep vein thrombosis | 6 | 15.8% | 1 | 5 |
| Drug interaction | 6 | 15.8% | 0 | 0 |
| Fatigue | 6 | 15.8% | 0 | 3 |
| Pulmonary embolism | 5 | 13.2% | 2 | 2 |
Other Indications for DOVITINIB
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)